775 related articles for article (PubMed ID: 18523270)
21. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
Komiyama Y; Nakae S; Matsuki T; Nambu A; Ishigame H; Kakuta S; Sudo K; Iwakura Y
J Immunol; 2006 Jul; 177(1):566-73. PubMed ID: 16785554
[TBL] [Abstract][Full Text] [Related]
22. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.
Jäger A; Dardalhon V; Sobel RA; Bettelli E; Kuchroo VK
J Immunol; 2009 Dec; 183(11):7169-77. PubMed ID: 19890056
[TBL] [Abstract][Full Text] [Related]
23. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen.
Vollmer TL; Liu R; Price M; Rhodes S; La Cava A; Shi FD
J Immunol; 2005 Mar; 174(5):2696-701. PubMed ID: 15728477
[TBL] [Abstract][Full Text] [Related]
25. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells.
Pál E; Tabira T; Kawano T; Taniguchi M; Miyake S; Yamamura T
J Immunol; 2001 Jan; 166(1):662-8. PubMed ID: 11123351
[TBL] [Abstract][Full Text] [Related]
26. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
27. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.
Matsushita T; Horikawa M; Iwata Y; Tedder TF
J Immunol; 2010 Aug; 185(4):2240-52. PubMed ID: 20624940
[TBL] [Abstract][Full Text] [Related]
28. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
29. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
30. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
31. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
Hofstetter HH; Shive CL; Forsthuber TG
J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
[TBL] [Abstract][Full Text] [Related]
32. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
33. Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient mice.
Schmidt CS; Zhao J; Chain J; Hepburn D; Gitter B; Sandusky G; Chintalacharuvu S; Glasebrook A; Na S
J Immunol; 2005 Aug; 175(4):2286-92. PubMed ID: 16081797
[TBL] [Abstract][Full Text] [Related]
34. Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system.
Du C; Sriram S
J Immunol; 2002 Mar; 168(6):3105-12. PubMed ID: 11884485
[TBL] [Abstract][Full Text] [Related]
35. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
36. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.
Teige I; Treschow A; Teige A; Mattsson R; Navikas V; Leanderson T; Holmdahl R; Issazadeh-Navikas S
J Immunol; 2003 May; 170(9):4776-84. PubMed ID: 12707359
[TBL] [Abstract][Full Text] [Related]
37. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
38. The kinetics of myelin antigen uptake by myeloid cells in the central nervous system during experimental autoimmune encephalomyelitis.
Sosa RA; Murphey C; Ji N; Cardona AE; Forsthuber TG
J Immunol; 2013 Dec; 191(12):5848-57. PubMed ID: 24227784
[TBL] [Abstract][Full Text] [Related]
39. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice.
Sun D; Whitaker JN; Huang Z; Liu D; Coleclough C; Wekerle H; Raine CS
J Immunol; 2001 Jun; 166(12):7579-87. PubMed ID: 11390514
[TBL] [Abstract][Full Text] [Related]
40. EAE mediated by a non-IFN-γ/non-IL-17 pathway.
Kroenke MA; Chensue SW; Segal BM
Eur J Immunol; 2010 Aug; 40(8):2340-8. PubMed ID: 20540117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
